A Study to Evaluate Imetalstat (JNJ-63935937) in Transfusion-Dependent Subjects with IPSS low or intermediate -1 Risk Myelodysplastic Syndrome (MDS) that is Relapsed/Refractory to Erythropoiesis- Stimulating Agent (ESA) Treatment

Type of Cancer
Myelodysplastic Syndrome

Sponsor
Janssen

Protocol Number
63935937MDS3001

To Learn More Call
(201)-510-0950